Indication
Interstitial cystitis
Interstitial cystitis, often termed bladder pain syndrome, is a chronic inflammatory disorder of the urinary bladder that predominantly affects adult women. Read more about Interstitial cystitis
5 drugs 5 manufacturers
Drugs that treat it
Common Interstitial cystitis therapies.
ELMIRON (pentosan polysulfate sodium)
ELMIRON (pentosan polysulfate sodium)
RIMSO-50 (dimethyl sulfoxide)
DIMETHYL SULFOXIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonInterstitial cystitis, often termed bladder pain syndrome, is a chronic inflammatory disorder of the urinary bladder that predominantly affects adult women.
It is characterized by persistent or recurrent pelvic, suprapubic, or perineal discomfort, pressure, or pain that typically worsens as the bladder fills and temporarily improves with voiding.
Patients frequently experience lower urinary tract irritative voiding symptoms, including persistent urinary urgency, extreme daytime frequency, and nocturia, in the absence of bacterial infection or other identifiable urologic pathology.
Pathophysiologically, the condition involves urothelial barrier disruption, mast cell activation, neurogenic inflammation, and sensory nerve upregulation, occasionally manifesting cystoscopically with characteristic mucosal findings such as glomerulations or Hunner lesions.
- nih.gov
Interstitial cystitis, often termed bladder pain syndrome, is a chronic inflammatory disorder of the urinary bladder that predominantly affects adult women
- nih.gov
Interstitial cystitis, often termed bladder pain syndrome, is a chronic inflammatory disorder of the urinary bladder that predominantly affects adult women Patients frequently experience lower urinary tract irritative voiding symptoms, including persistent urinary urgency, extreme daytime frequency, and nocturia, in the absence of bacterial infection or other identifiable urologic pathology Pathophysiologically, the condition involves urothelial barrier disruption, mast cell activation, neurogen...
- nih.gov
It is characterized by persistent or recurrent pelvic, suprapubic, or perineal discomfort, pressure, or pain that typically worsens as the bladder fills and temporarily improves with voiding Patients frequently experience lower urinary tract irritative voiding symptoms, including persistent urinary urgency, extreme daytime frequency, and nocturia, in the absence of bacterial infection or other identifiable urologic pathology
- nih.gov
It is characterized by persistent or recurrent pelvic, suprapubic, or perineal discomfort, pressure, or pain that typically worsens as the bladder fills and temporarily improves with voiding Patients frequently experience lower urinary tract irritative voiding symptoms, including persistent urinary urgency, extreme daytime frequency, and nocturia, in the absence of bacterial infection or other identifiable urologic pathology Pathophysiologically, the condition involves urothelial barrier disrupt...
- nih.gov
Patients frequently experience lower urinary tract irritative voiding symptoms, including persistent urinary urgency, extreme daytime frequency, and nocturia, in the absence of bacterial infection or other identifiable urologic pathology
Personalize your experience
Follow Interstitial cystitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.